{"id":136569,"date":"2022-02-10T20:02:25","date_gmt":"2022-02-10T12:02:25","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=422888"},"modified":"2022-02-10T20:02:25","modified_gmt":"2022-02-10T12:02:25","slug":"astrazeneca-says-covid-vaccine-demand-high-in-latam-middle-east-asia-3","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2022\/02\/10\/astrazeneca-says-covid-vaccine-demand-high-in-latam-middle-east-asia-3\/","title":{"rendered":"AstraZeneca says COVID vaccine demand high in Latam, Middle East, Asia"},"content":{"rendered":"<p>Astrazeneca said global interest in government purchase agreements for its COVID-19 vaccine was driven by strong demand in Latin America, the Middle East and<\/p>\n<p>Astrazeneca said global interest in government purchase agreements for its COVID-19 vaccine was driven by strong demand in Latin America, the Middle East and Asia, even as aggregate global demand this year will fall.&#8230;<\/p>\n<p>This data comes from the <a href=\"https:\/\/www.chinapulse.com\/\" title=\"ChinaPulse.com provides Media Intelligence and Media Monitoring in China\" >ChinaPulse.com media intelligence and smart news insights monitoring platform<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astrazeneca said global interest in government purchase agreements for its COVID-19 vaccine was driven by strong demand in Latin America, the Middle East and<br \/>\nAstrazeneca said global interest in government purchase agreements for its COVID-19 vaccine wa&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[213,194,465,1242,484,1367],"tags":[2210,10324,10557,2249,7035],"class_list":["post-136569","post","type-post","status-publish","format-standard","hentry","category-china-news","category-news-chinese-law","category-social-media","category-twitter","category-united-states","category-usa","tag-america","tag-covid-19","tag-latin-america","tag-middle-east","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/136569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=136569"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/136569\/revisions"}],"predecessor-version":[{"id":136570,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/136569\/revisions\/136570"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=136569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=136569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=136569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}